Dermatology products will make up about $730 million in estimated 2012 revenue for Medicis, Gregory Waterman, an analyst for Goldman Sachs, said in a note to clients today. Medicis gross profit margin was 20 percentage points higher than Valeant in 2011 at 91 percent, according to data compiled by